India may look into vaccine interchangeability trial

News Today 01.06.2021

Speaking about the possibility of a interchangeable dose regime trial, NITI Aayog member (Health) V.K. Paul said: “There is growing scientific interest in the matter worldwide and India too should look into it. This is a biological plausibility and if proven effective it could go a long way in enhancing faster coverage and acting as a better booster dose that can be offered for use.” (Read More)


Be the first to comment

Leave a Reply

Your email address will not be published.